Baxter International Inc (BAX)
36.32
+1.24
(+3.53%)
USD |
NYSE |
Oct 04, 16:00
36.26
-0.06
(-0.17%)
After-Hours: 20:00
Baxter International SG&A Expense (Annual): 3.896B for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 3.896B |
December 31, 2022 | 3.833B |
December 31, 2021 | 2.853B |
December 31, 2020 | 2.515B |
December 31, 2019 | 3.29B |
December 31, 2018 | 2.621B |
December 31, 2017 | 2.629B |
December 31, 2016 | 2.746B |
December 31, 2015 | 3.094B |
December 31, 2014 | 3.315B |
December 31, 2013 | 3.084B |
December 31, 2012 | 3.283B |
December 31, 2011 | 3.154B |
December 31, 2010 | 2.907B |
December 31, 2009 | 2.731B |
December 31, 2008 | 2.698B |
December 31, 2007 | 2.521B |
December 31, 2006 | 2.282B |
December 31, 2005 | 2.03B |
December 31, 2004 | 1.96B |
Date | Value |
---|---|
December 31, 2003 | 1.805B |
December 31, 2002 | 1.566B |
December 31, 2001 | 1.44B |
December 31, 2000 | 1.33B |
December 31, 1999 | 1.311B |
December 31, 1998 | 1.208B |
December 31, 1997 | 1.145B |
December 31, 1996 | 1.142B |
December 31, 1995 | 1.084B |
December 31, 1994 | 1.859B |
December 31, 1993 | 2.983B |
December 31, 1992 | 2.196B |
December 31, 1991 | 2.182B |
December 31, 1990 | 2.541B |
December 31, 1989 | 1.811B |
December 31, 1988 | 1.749B |
December 31, 1987 | 1.55B |
December 31, 1986 | 1.534B |
December 31, 1985 | 657.00M |
December 31, 1984 | 529.10M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
2.515B
Minimum
2020
3.896B
Maximum
2023
3.277B
Average
3.29B
Median
2019
SG&A Expense (Annual) Benchmarks
Boston Scientific Corp | 5.19B |
Haemonetics Corp | 431.78M |
Masimo Corp | 664.00M |
Accuray Inc | 92.68M |
Insulet Corp | 734.90M |